2m 2m 2m 2m 2m 2m 2m
MUSTANG BIO (MBIO)
NASDAQ
$0.75+$0.01 (+1.43%)
Price as of Jun 03, 2026 6:14 PM EDT- $4.5MMarket Cap
- -40.97%1-Year Change
- BiotechnologyIndustry
MUSTANG BIO (MBIO)
$0.75+$0.01 (+1.43%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cost of Revenue | 500,000 0.00% | 500,000 -50.00% | 1.0M N/A | N/A N/A | |
Gross Profit | -500,000 0.00% | -500,000 -50.00% | -1.0M N/A | 0 N/A | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | N/A N/A | -7.6M -81.35% | -40.5M -35.15% | -62.5M +25.29% | |
Depreciation and Amortization Expense | 34,000 -94.93% | 671,000 -63.92% | 1.9M -31.69% | 2.7M +25.66% | |
Total Operating Expenses | 2.4M -85.03% | 16.2M -67.02% | 49.3M -35.32% | 76.2M +14.14% | |
Operating Profit | -2.4M -85.03% | -16.2M -67.02% | -49.3M -35.32% | -76.2M +14.14% | |
Interest Income | 511,000 +177.72% | 184,000 -78.35% | 850,000 +23.37% | 689,000 +87.23% | |
Interest Expense | N/A N/A | -5,000 -99.88% | -4.1M +22.33% | -3.4M +59.95% | |
Interest Income and Expense and Net | 511,000 +185.47% | 179,000 +105.49% | -3.3M +22.06% | -2.7M +54.16% | |
Total Nonoperating Income and Expense | 511,000 +3.65% | 493,000 +121.05% | -2.3M +71.45% | -1.4M -486.97% | |
Income before Taxes | -1.9M -88.17% | -16.2M -67.02% | -49.3M -35.32% | -76.2M +14.14% | |
Income Taxes | 27,000 N/A | N/A N/A | N/A N/A | N/A N/A | |
Extraordinary Items | 0 -100.00% | 3.7M N/A | N/A N/A | N/A N/A | |
Net Income | -1.9M -87.80% | -15.8M -69.47% | -51.6M -33.44% | -77.5M +16.81% | |
Net Income from Continuing Operations Applicable to Common | -1.9M -87.80% | -15.8M -69.47% | -51.6M -33.44% | -77.5M +16.81% | |
Basic EPS and Net Income | -0.39 -98.99% | -38.57 +542.83% | -6.00 +700.00% | -0.75 -1.32% | |
Diluted EPS and Net Income | -0.39 -98.99% | -38.57 +542.83% | -6.00 +700.00% | -0.75 -1.32% | |
Basic Weighted Average Shares | 4.9M +705.02% | 609,696 -92.91% | 8.6M -91.68% | 103.4M +17.69% | |
Diluted Weighted Average Shares | 4.9M +705.02% | 609,696 -92.91% | 8.6M -91.68% | 103.4M +17.69% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 17.3M +152.46% | 6.8M +9.70% | 6.2M -91.76% | 75.7M -30.98% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 17.3M +152.46% | 6.8M +9.70% | 6.2M -91.76% | 75.7M -30.98% | |
Total Current Assets | 17.6M +104.43% | 8.6M -24.15% | 11.3M -85.61% | 78.9M -29.41% | |
Accumulated Depreciation | N/A N/A | 5.1M +14.99% | 4.5M -46.72% | 8.4M +46.51% | |
Property and Plant and Equipment and Net | 0 -100.00% | 371,000 -88.47% | 3.2M -65.73% | 9.4M -15.03% | |
Total Long-Term Assets | 0 -100.00% | 250,000 -69.99% | 833,000 +219.16% | 261,000 -27.90% | |
Total Assets | 17.6M +89.01% | 9.3M -47.54% | 17.7M -80.80% | 92.4M -26.16% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | 766,000 +5.95% | |
Total Current Liabilities | 7.9M -37.24% | 12.6M -17.97% | 15.4M +1.73% | 15.1M +39.70% | |
Total Long-Term Debt | N/A N/A | N/A N/A | 0 -100.00% | 27.4M N/A | |
Total Long-Term Liabilities | 150,000 -73.78% | 572,000 -74.56% | 2.2M -92.76% | 31.0M +1,487.72% | |
Total Liabilities | 8.1M -38.82% | 13.2M -25.19% | 17.6M -61.82% | 46.1M +261.39% | |
Retained Earnings | -398.6M +0.48% | -396.7M +4.13% | -381.0M +15.67% | -329.4M +30.78% | |
Total Stockholders Equity | 9.5M +346.04% | -3.9M -3,248.78% | 123,000 -99.73% | 46.3M -58.83% | |
Total Shares Outstanding | 845,385 0.00% | 845,385 -90.83% | 9.2M -91.41% | 107.3M +13.68% | |
Cash Flow | |||||
Cash from Operating Activities | -5.3M -53.87% | -11.4M -76.94% | -49.5M -23.96% | -65.1M +21.24% | |
Capital Expenditures | N/A N/A | 0 -100.00% | 64,000 -97.64% | 2.7M -31.91% | |
Cash from Investing Activities | 1.2M N/A | 0 -100.00% | 5.9M +299.39% | -3.0M -44.99% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 14.5M +28.95% | 11.3M +143.19% | -26.1M -176.58% | 34.1M -51.93% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Return on Assets | -14.28% -87.74% | -116.47% +24.32% | -93.68% +31.47% | -71.26% +26.19% | |
Return on Equity | -67.93% -108.09% | 840.11% +477.68% | -222.44% +127.64% | -97.72% +55.21% | |
Revenue Growth | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Current Ratio | 2.22 +225.71% | 0.68 -7.53% | 0.74 -85.86% | 5.22 -49.47% | |
Cash Ratio | 2.18 +302.23% | 0.54 +33.73% | 0.41 -91.90% | 5.01 -50.60% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | 0.61 N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | 0.31 N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow